Kelsey Wuest
Adult Health · Annapolis, MDNPI 1568120574
Payments from drug & device makers
Across 92 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$308
- Exact Sciences$250
- AbbVie$227
- Novo Nordisk$198
- Boehringer Ingelheim$159
- Pfizer$132
- plus $664 from 21 others
What the payments were for
- Food & beverage$1,938100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 16 | $308 |
| Exact Sciences | 10 | $250 |
| AbbVie | 10 | $227 |
| Novo Nordisk | 10 | $198 |
| Boehringer Ingelheim | 8 | $159 |
| Pfizer | 5 | $132 |
| Merck | 4 | $95 |
| Astellas Pharma US Inc | 3 | $71 |
| AstraZeneca | 3 | $63 |
| Dexcom, Inc. | 3 | $62 |
| Gilead | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| UCB, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Vertical Pharmaceuticals, LLC | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $22 |
| BD | 1 | $19 |
| Amryt Pharma Holdings Ltd | 1 | $19 |
| Dynavax Technologies Corporation | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Amgen | 1 | $17 |
| Medtronic | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Philips North America LLC | 1 | $13 |
How this compares
$1,938 in reported general payments places this provider in the 80th percentile of 542 adult health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $366 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 48 | $339 |
| Fluticasone Propionate | 20 | $201 |
| Doxycycline Hyclate | 27 | $190 |
| Prednisone | 50 | $102 |
| Azithromycin | 25 | $92 |
| Ondansetron OdtOndansetron | 12 | $86 |
| CefuroximeCefuroxime Axetil | 13 | $74 |
| Ciprofloxacin Hcl | 18 | $34 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $27 |
Paid to pharmacies, not to this prescriber.
Other adult health in Annapolis
- Caroline RuhlAnnapolis$315K
- Erin BrimhallAnnapolis$8K
- Lucia NovakCamp Springs$473K
- Joyce MiskovicHighland$264K
- Christopher RobersonBaltimore$180K
- Amit DhirBaltimore$97K
- Angie PriceBaltimore$96K
- Morgan JoliatSykesville$92K
- Brendon BowerBaltimore$64K
- Caitlin NassBaltimore$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.